12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice lethally infected with H3N2 virus, oral FluCide led to a survival time of 15.6 days vs. 9.6 days for

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >